Your browser doesn't support javascript.
loading
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Wang, Eunice S; Montesinos, Pau; Minden, Mark D; Lee, Je-Hwan; Heuser, Michael; Naoe, Tomoki; Chou, Wen-Chien; Laribi, Kamel; Esteve, Jordi; Altman, Jessica K; Havelange, Violaine; Watson, Anne-Marie; Gambacorti-Passerini, Carlo; Patkowska, Elzbieta; Liu, Shufang; Wu, Ruishan; Philipose, Nisha; Hill, Jason E; Gill, Stanley C; Rich, Elizabeth Shima; Tiu, Ramon V.
Afiliação
  • Wang ES; RoswellPark Comprehensive Cancer Center, Buffalo, NY.
  • Montesinos P; Hospital Universitari i Politècnic La Fe, Valencia & CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Minden MD; Princess Margaret Hospital, Toronto, ON, Canada.
  • Lee JH; Asan Medical Center, Seoul, South Korea.
  • Heuser M; Hannover Medical School, Hannover, Germany.
  • Naoe T; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Chou WC; National Taiwan University Hospital, Taipei, Taiwan.
  • Laribi K; Hematology Department, Centre Hospitalier Du Mans, Le Mans, France.
  • Esteve J; Hospital Clinic de Barcelona, Barcelona, Spain.
  • Altman JK; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL.
  • Havelange V; Cliniques Universitaires St. Luc, Brussels, Belgium.
  • Watson AM; Liverpool Hospital, Liverpool, NSW, Australia.
  • Gambacorti-Passerini C; University of Milano-Bicocca, Monza, Italy.
  • Patkowska E; Hematology Division, ASST Monza, Monza, Italy.
  • Liu S; Hematology Department, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Wu R; Astellas Pharma US, Northbrook, IL.
  • Philipose N; Astellas Pharma US, Northbrook, IL.
  • Hill JE; Astellas Pharma US, Northbrook, IL.
  • Gill SC; Astellas Pharma US, Northbrook, IL.
  • Rich ES; Astellas Pharma US, Northbrook, IL.
  • Tiu RV; Astellas Pharma US, Northbrook, IL.
Blood ; 140(17): 1845-1857, 2022 10 27.
Article em En | MEDLINE | ID: mdl-35917453

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2022 Tipo de documento: Article